Open access
Jul 2026
SH3BGRL3 is a pancancer prognostic and immunological biomarker.
Pan-cancer analysis revealed that SH3BGRL3 expression was upregulated in most tumors, and correlated with unfavorable outcomes and advanced tumor stages of various cancers, and served as a promising prognostic and immunological biomarker exhibiting cancer-type-specific variations.
Yuntao Yao, Zihui Zhao, Bingnan Lu et al.
· Discover Oncology · 0 citations